Patient-reported health state utilities in metastatic gastroenteropancreatic neuroendocrine tumours – an analysis based on the CLARINET study

Table 4 Summary of estimated utility decrements for progressive disease versus stable disease

Model	McKenzie algorithm [16] (base case)				Longworth algorithm [15]
Model	Coefficient	95% CI		p-value	Coefficient	95% CI		p-value
1 (base case)	−0.0495	−0.0840	−0.0150	0.005	−0.0284	−0.0586	0.0019	0.066
2	−0.0499	−0.0845	−0.0154	0.005	−0.0292	−0.0595	0.0011	0.059
3	−0.0496	−0.0842	−0.0150	0.005	−0.0288	−0.0591	0.0015	0.062
4	−0.0500	−0.0846	−0.0153	0.005	−0.0291	−0.0594	0.0013	0.061

ISSN: 1477-7525